These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2650421)

  • 1. Prevention of graft-versus-host disease in neonatal F1 hybrid mice by pre-immunisation of their mother with paternal spleen cells.
    DeGiorgi L; Povey S; Habeshaw JA; Davies AJ
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3045-9. PubMed ID: 2650421
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
    Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of graft-versus-host disease in neonatal F1 hybrid mice.
    DeGiorgi L; Habeshaw JA; Povey S; Matossian-Rogers A
    Clin Exp Immunol; 1990 Jan; 79(1):130-4. PubMed ID: 2302831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Graft vs host reaction in reciprocal combinations of mouse strains differing by the H-2 complex of histocompatibility].
    Maianskiĭ DN
    Biull Eksp Biol Med; 1976 Aug; 82(8):974-7. PubMed ID: 16675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine graft-versus-host disease in an F1-hybrid model using IFN-gamma gene knockout donors.
    Ellison CA; Fischer JM; HayGlass KT; Gartner JG
    J Immunol; 1998 Jul; 161(2):631-40. PubMed ID: 9670937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratinocytes synthesize Ia antigen in acute cutaneous graft-vs-host disease.
    Breathnach SM; Katz SI
    J Immunol; 1983 Dec; 131(6):2741-5. PubMed ID: 6417231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose heparin inhibits acute graft versus host disease in mice.
    Naparstek E; Slavin S; Weiss L; Sidi H; Ohana M; Reich S; Vlodavsky I; Cohen IR; Naparstek Y
    Bone Marrow Transplant; 1993 Sep; 12(3):185-9. PubMed ID: 8241974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of asialo-GM1+ cells from the F1 recipient mice prior to irradiation and transfusion of parental spleen cells prevents mortality to acute graft-versus-host disease and induction of anti-host specific cytotoxic T cells.
    Varkila K
    Clin Exp Immunol; 1987 Sep; 69(3):652-9. PubMed ID: 3499271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The suppression of graft-versus-host disease in mice by endotoxin-treated adherent spleen cells.
    Thomson PD; Jutila JW
    J Reticuloendothel Soc; 1974 Dec; 16(6):327-9. PubMed ID: 4616077
    [No Abstract]   [Full Text] [Related]  

  • 10. Active suppression of host-vs-graft reaction in pregnant mice. VII. Spontaneous abortion of allogeneic CBA/J x DBA/2 fetuses in the uterus of CBA/J mice correlates with deficient non-T suppressor cell activity.
    Clark DA; Chaput A; Tutton D
    J Immunol; 1986 Mar; 136(5):1668-75. PubMed ID: 2936806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease.
    Azuma E; Yamamoto H; Kaplan J
    J Immunol; 1989 Sep; 143(5):1524-9. PubMed ID: 2668409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific graft-versus-host nonreactivity of lymphoid cells from irradiation chimeras.
    Norin AJ; Emeson EE; Veith FJ
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1241-4. PubMed ID: 7268889
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental model of graft vs. host disease in non-immunosuppressed F1 (CBA/J x C57BL/6) mice.
    Acosta A; Sarmiento ME; Infante JF; Sierra G; Izquierdo L; Capó V; Zamanillo T
    Arch Med Res; 1994; 25(2):151-4. PubMed ID: 7919803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of genetic differences between mother and fetuses in the development of the graft vs host reaction induced in the mother].
    Fedosov EA; Fedorov GN; Kostiukov AA
    Biull Eksp Biol Med; 1980 Mar; 89(3):340-2. PubMed ID: 7388144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lethal systemic graft-vs-host disease in neonatally tolerant, but not in F1 hybrid mice.
    Vizler C; Jánossy T; Baranyi L; Végh P
    Cell Immunol; 1993 Feb; 146(2):431-7. PubMed ID: 8174181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific depletion of graft-versus-host activity of normal or allosensitized parental spleen cells.
    Rózalska B
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):417-21. PubMed ID: 6200087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and treatment of graft-versus-host disease by down-regulation of anti-host reactivity with veto cells of host origin.
    Weiss L; Slavin S
    Bone Marrow Transplant; 1999 Jun; 23(11):1139-43. PubMed ID: 10382953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of graft versus host reactivity by a single host-specific blood transfusion to prospective donors of hemopoietic cells.
    Knulst AC; Bril-Bazuin C; Ruizeveld de Winter JA; Benner R
    Transplant Proc; 1990 Aug; 22(4):1975-6. PubMed ID: 2389502
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.
    Ushiyama C; Hirano T; Miyajima H; Okumura K; Ovary Z; Hashimoto H
    J Immunol; 1995 Mar; 154(6):2687-96. PubMed ID: 7876541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.